Novo Nordisk ousts CEO as Wegovy maker faces growing competition
Global Economy May 16, 2025
Novo Nordisk CEO Lars Jorgensen testifies before a Senate Health, Education, Labor, and Pensions Committee hearing on U.S. prices for the weight loss drugs Ozempic and Wegovy, on Capitol Hill in Washington, U.S., September 24, 2024.
Piroschka Van De Wouw | Reuters
Novo Nordisk said Friday that CEO Lars Fruergaard Jørgensen is stepping down as the Wegovy maker seeks to revive its ailing fortunes amid increasing competition.
The Danish pharmaceutical giant said Jørgensen, who was at the helm for eight years, would remain in his post 'for a period to support a smooth transition to new leadership.' It added that the search for a successor was ongoing and an announcement would be made in due course.
Novo Nordisk shares closed 1.8% lower Friday. Meanwhile, shares of rival obesity drug maker Eli Lilly were 1.7% higher following the announcement.
The decision comes as Novo Nordisk's stock price has taken a battering over the past year amid increased competition in the ballooning obesity drug market and disappointing trial results for its next-generation treatments.
The company's share price is currently down by more than 50% since the middle of 2024.
Board Chairman Helge Lund said discussions to replace Jørgensen had been ongoing for the past several weeks between Novo Nordisk and the Novo Nordisk Foundation, which controls the firm, according to Reuters.
Reuters separately reported Jørgensen as telling Danish broadcaster TV2 that he was only informed very recently and that he did not see the decision coming.
'Novo Nordisk's strategy remains unchanged, and the Board is confident in the company's current business plans and its ability to execute on the plans,' Lund said in a statement announcing the decision.
'The changes are, however, made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company's share price since mid-2024,' the company said in a statement.
In connection with the change, the company said that Lars Rebien Sørensen, former Novo CEO and current chair of the Novo Nordisk Foundation, will join Novo Nordisk's board, initially as an observer.
Novo last week reported lower-than-expected first-quarter sales of its flagship Wegovy obesity drug and trimmed its full-year sales growth forecast amid increased competition from compounded drug markets in the U.S.
'Compounders took a part of our business away,' Jørgensen told CNBC's Charlotte Reed.
The company nevertheless said that it expected sales to improve in the second half of the year as the availability of copycat compounded drugs is phased out after the Food and Drug Administration ended its drug shortage ruling.
Novo has meanwhile struggled to shake negative sentiment following a series of disappointing trial results for its next-generation obesity drug candidate CagriSema. Jørgensen previously said he was 'very optimistic' about the prospects for the treatment.
'From the data we have, CagriSema is the best product that has been tested out or is on the market, and we believe we can get those data even better.'
READ SOURCE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Why the RBA opted for smaller rate cut
Global uncertainty on the back of the US President Donald Trump's tariff policy and a weakening Australian economy saw the Reserve Bank of Australia debate an outsized rate cut last month. Minutes from the RBA's May 20 policy meeting show the central bank is still nervous about the impact of Mr Trump's trade policy but wants to move 'cautiously and predictably' in line with market expectations. As such, households were not given an outsized 'insurance against global growth' 50 basis point rate cut. Instead, the bank highlighted the need for monetary policy settings to remain 'predictable at a time of heightened uncertainty'. 'They agreed that developments in the domestic economy on their own justified a reduction in the cash rate target and that the case for that action was strengthened by developments in global trade policy,' the minutes reveal. Ultimately though, the board agreed the case for a 25 basis point rate cut was 'the stronger one' as members were not persuaded that weakening global growth and domestic factors warranted an outsized rate cut. In a silver lining for households, should the impacts of global uncertainty materialise, the RBA board agreed it would need to move to 'expansionary settings' meaning there would be more cuts to the cash rate. The board judged in May however that there was not enough data around the impacts of any global uncertainty to switch to a more expansive monetary policy setting. 'They also judged it was not yet time to move monetary policy to an expansionary stance, taking account of the range of estimates involved, given that inflation was yet to return sustainably to the midpoint of the target range and the staff's assessment that the labour market was still tight,' the minutes read. The board also highlighted they had the firepower left to kickstart global growth should the worst of global uncertainty impact the local economy. 'In finalising the policy statement, members agreed that it was appropriate to convey their commitment to both of the Board's objectives,' the board said. 'They also agreed to convey that policy was well placed to respond decisively to international developments if they were to have material implications for activity and inflation of the kind described in the severe downside scenario set out in the May Statement on Monetary Policy.' Meeting for the second time under its new dual-board structure, the RBA cut the national cash rate by 25 basis points, from 4.10 to 3.85 per cent, but RBA governor Michele Bullock revealed a 50 basis point cut had been debated. 'There was an argument and we did debate it (a 50 basis point cut) but it wasn't the strongest argument in the room,' Ms Bullock said at the time. She stressed 'inflation hurts everyone', particularly those on lower incomes and renters. Responding to a question from NewsWire on whether households could expect further relief, and what message she had for those doing it tough, she acknowledged Australians had gone through a 'really rough few years', accentuated by sharp rises in everyday prices. 'I would say that bringing inflation down is the best thing we can do to help them, while keeping employment strong,' she said. 'At the moment we are on track to deliver that. I know you're doing it tough, but conditions are improving.' Error in retrieving data Sign in to access your portfolio Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Mama June Praises The Benefits Of Weight Loss Shots After Quitting It
Mama June is in her healthy era! The reality star is choosing to live a healthy life, and the process has been rewarding, as she has now discontinued her weight loss medications. Mama June's struggle with weight management has been a central point in her life for years. She previously went under the knife for weight loss surgery in 2016. The TV star recently shared exciting news about her health journey, revealing she has stopped using weight loss medication. Mama June confirmed that she has not relied on weight loss shots since December and has successfully maintained her weight through lifestyle changes. She highlighted the benefits of weight loss shots, particularly for individuals managing medical conditions. "I tell you all the time, if you choose to go on the weight loss shot, it has so many benefits. Not just for weight loss, but for, like, people who have like PCOS, women's issues, people who have inflammation, people who have other issues going on," she said. The reality star began her weight loss journey with injections in April 2024, eight years after undergoing weight loss surgery in 2016, which helped her reach a weight of 195 pounds. However, she struggled to maintain her weight as she faced challenges during her eldest daughter Anna Cardwell's cancer battle. Mama June was even more overwhelmed when her efforts to salvage Anna's life did not yield, and she unfortunately passed at the age of 29 in December 2023. In June 2024, June opened up about taking medications for her weight loss. In her words: "I've been on weight loss medication. I was first on Semaglutide, which is like Ozempic. And now I'm on Triglycerides for the last three weeks." She also claimed the medications were super helpful at the time, with zero side effects to threaten her health. Today, In Touch confirmed that she appears to be focusing on her health sustainably, celebrating her progress while promoting the new season of "Mama June: Family Crisis." In her revelation last year, she added that she also kept the weight off by exercising "three or four times a week." She reflected on her past experiences with gastric procedures, expressing her initial aversion to the potential side effects like nausea and vomiting. However, she noted that since starting her new medication, she has experienced no adverse effects and has avoided sweets and sodas. June mentioned that while diabetes medications are often associated with lowering blood sugar, she has had no issues in that area since beginning treatment. She spotted the difference in weight loss rates between her previous surgery and the medication. According to her: "I've just been really good and consistent. The only difference [for] this medicine and the gastric sleeve is I lost 160 pounds in four weeks [with the surgery] and with this I lose four pounds a week." The reality star has documented her weight loss on social media, sharing that as of September 2024, she had lost a total of 60 pounds. Since Anna's passing, a whole lot has changed for Mama June and her family. Her last daughter, Alana, now 19, has relocated to Colorado to pursue a degree in nursing. Alana became popular on TV following her appearance on TLC's "Toddlers & Tiaras." She quickly became a reality TV sensation with her confident catchphrase, "Honey Boo Boo Child!" Along with her entertaining family, she starred in a series of shows and specials that instantly brought her fame. Reflecting on her rise to stardom, Alana expressed her bewilderment over how she came up with her iconic phrase, stating, "To this day, I still cannot tell you what I thought when I was saying 'Honey Boo Boo Child.'" Now that she has moved to Georgia, which she had always known as home, Alana admits, "Absolutely, no. I do not miss Georgia. I don't miss a thing about Georgia," though she acknowledges missing the people she left behind. With a sense of humor about her past as a reality star, she noted that she might still be known as 'Honey Boo Boo' even at 60, joking about being approached for photos in a nursing home. Anna's battle with cancer has also intensified Alana's desire to help others. She was deeply affected by the care Anna received and the positive impact of her nurses, which inspired Alana to pursue a career in nursing. As shared by TODAY, she expressed her aspiration to be a supportive nurse, reflecting her commitment to helping others in times of need. Last year, The Blast shared that Mama June opened up about the profound emptiness left by her daughter Anna Cardwell's passing. She shared the challenging reality her family has faced since losing Anna, detailing the impact on her granddaughters, 12-year-old Kaitlyn and 8-year-old Kylee. The loss has been especially difficult for the girls, with Mama June noting the significant struggles they have had to endure. In addition to dealing with the grief, Mama June has navigated a complicated custody situation. Following Anna's death, she fought and won a custody battle for Kaitlyn against her former son-in-law, Michael Cardwell. This battle was worsened by Michael's move to Alabama, which disrupted their family arrangement. Mama June decided to stay in Georgia despite her plans to relocate to prevent Kylee from moving away. Despite the daunting situation, Mama June shared her commitment to keeping Anna's husband, Eldridge Toney, involved in the lives of her granddaughters, honoring Anna's wishes in the process. Things got heated during the custody battle with Michael. While Anna's former husband claimed Anna and Mama June were not on good terms before her death, the reality star set the record straight. According to Mama June, Michael was the abusive one during his marriage to her late daughter. She claimed Michael constantly abused Anna and Kaitlyn. The court eventually ruled that Mama June would retain Kaitlyn's legal and physical custody. The court also placed restrictions on Michael, prohibiting him from contacting Mama June or Kaitlyn unless they both agreed to a visitation arrangement. Kaitlyn, who has been residing with her grandmother since Anna's battle with cancer, had previously expressed her strong desire to stay with Mama June during testimony in court. Big ups to Mama June for doing the best for her wellness despite what life is throwing at her.
Yahoo
8 hours ago
- Yahoo
Parex Resources Announces Appointment to the Board of Directors
CALGARY, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Parex Resources Inc. ('Parex' or the 'Company') (TSX: PXT) is pleased to announce the appointment of Alberto Consuegra to the Board of Directors (the 'Board'). Effective June 1, 2025, Alberto Consuegra has been appointed to the Board as an independent director. Alberto has more than 30 years of experience in the energy sector. Most recently, Mr. Consuegra served as the Chief Operating Officer of Ecopetrol, Colombia's national oil company, and for a period of time acted as the Company's interim Chief Executive Officer. He has also served as the President of Cenit Transporte y Logística de Hidrocarburos S.A.S., the Vice President of Supply and Services of Ecopetrol, and held several executive positions at Equion Energia Ltd. and BP Exploration. Mr. Consuegra graduated from Universidad de Cartagena with a civil engineering degree and holds a master's degree in civil engineering from Texas A&M University. 'We are excited to welcome Alberto to our Board of Directors and believe his Colombia-focused energy expertise will contribute to the ongoing success of Parex,' commented Wayne Foo, Chair of Parex's Board of Directors. About Parex Resources Inc. Parex is one of the largest independent oil and gas companies in Colombia, focusing on sustainable conventional production. The Company's corporate headquarters are in Calgary, Canada, with an operating office in Bogotá, Colombia. Parex shares trade on the Toronto Stock Exchange under the symbol PXT. For more information, please contact: Mike KruchtenSenior Vice President, Capital Markets & Corporate PlanningParex Resources Inc. Steven EirichSenior Investor Relations & Communications AdvisorParex Resources NOT FOR DISTRIBUTION OR FOR DISSEMINATION IN THE UNITED STATES PDF available:
